Global lipid metabolic pathways

Global lipid metabolic pathways encompass the integrated network of biochemical processes responsible for the synthesis, transport, and degradation of lipids, such as fatty acids, triglycerides, and cholesterol (StatPearls, 2023). These pathways are fundamental to maintaining cellular membrane integrity, providing energy through beta-oxidation, and serving as precursors for signaling molecules like prostaglandins and steroid hormones (NIH, 2022). Dysregulation within these pathways is a primary driver of metabolic disorders, including atherosclerosis, non-alcoholic fatty liver disease (NAFLD), and type 2 diabetes (PubMed, 2021).\n\nWhile Global lipid metabolic pathways is a systemic classification rather than a single therapeutic target, pharmacological agents frequently target specific enzymes or receptors within this network. For example, statins inhibit HMG-CoA reductase to lower cholesterol, while fibrates activate PPAR-alpha to enhance fatty acid oxidation (Nature Reviews Drug Discovery, 2020). Other interventions include PCSK9 inhibitors and NPC1L1 blockers, which modulate lipoprotein clearance and absorption respectively (PubMed, 2022). The complexity of these pathways necessitates a systems-biology approach to understand how individual targets influence the broader metabolic state. Consequently, this term is often used in research to describe broad metabolic profiles or multi-target therapeutic strategies rather than a discrete molecular entity. Monitoring these pathways involves measuring circulating lipid levels and apolipoproteins to assess cardiovascular risk and treatment efficacy (PubMed, 2023).

Other names

Lipid metabolismLipid metabolic processesFatty acid and cholesterol metabolism

Inhibition of HMG-CoA reductase, activation of PPAR-alpha, inhibition of NPC1L1, and inhibition of PCSK9 (StatPearls, 2023; PubMed, 2022).